JULY 2018

Treating BRCA1/2 Metastatic Breast Cancer

Reading this article from Breastcancer.org along with the FDA’s press release and a viewpoint by cancer writer Elaine Schattner, provides three perspectives and good context for women with BRCA+ metastatic breast cancer wondering if Lynparza is right for them.

• • Breastcancer.org: Lynparza Approved for Metastatic HER2-Negative BRCA+ Breast Cancer
  • FDA: FDA Approves First Treatment for Metastatic BRCA Breast Cancer
  • Elaine Schattner’s viewpoint:  PARP Drugs Like Lynparaza May Help Some